Omar AbdiHamid: Our study on biomarkers of Immunotherapy response

Quoting Omar AbdiHamid, Clinical Oncology Specialist at HCGCCK Cancer Centre, on LinkedIn:

”Publication Alert. Our study on biomarkers of Immunotherapy response showed that high neutrophil lymphocyte ratio (NLR) and Platelets lymphocyte ratio (PLR) either at baseline or during treatment is associated with poorer treatment outcome. Therefore, these ratios can be utilized in clinical practice with other markers to determine treatment efficacy from immunotherapy.”

For the article click here.
Source: Omar AbdiHamid/LinkedIn